Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and pharmacokinetics as well as the
biodistribution of OTSA101-DTPA-111In and to evaluate the safety of intravenous
administration of OTSA101-DTPA-90Y.